Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
In Vivo · 2024
DOI: 10.21873/invivo.13775 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Toru Aoyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yokohama City University, Yokohama, Japan t-aoyama@lilac.plala.or.jp. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND/AIM: We hypothesized that the inflammatory burden index (IBI) is a promising biomarker for esophageal cancer (EC) treatment and management. To confirm our hypothesis, we evaluated the prognostic impact of IBI in patients with EC who received curative treatment. PATIENTS AND METHODS: We conducted a retrospective review of medical records and collected data from consecutive patients with EC who underwent curative resection at Yokohama City University between 2005 and 2020. The IBI score was calculated as the C-reactive protein level multiplied by the neutrophil-to-lymphocyte ratio. RESULTS: In total, 180 patients with EC were included in this study. The 3- and 5-year overall survival (OS) rates were 72.9% and 63.4%, respectively, in the IBI-low group, and 38.2% and 32.5% in the IBI-high group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Yokohama City University, Yokohama, Japan t-aoyama@lilac.plala.or.jp.
- Department of Surgery, Yokohama City University, Yokohama, Japan.
- Department of Surgery, Yokohama City University, Yokohama, Japan itarum1n1@hotmail.com.
Zitieren
APA
Aoyama, T., Maezawa, Y., Hashimoto, I., Esashi, R., Yamamoto, S., Kazama, K., Numata, K., Uchiyama, M., Tamagawa, A., Saito, A., & Yukawa, N. (2024). Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment. In Vivo. https://doi.org/10.21873/invivo.13775
Vancouver
Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Yamamoto S, Kazama K, et al. Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment. In Vivo. 2024. doi:10.21873/invivo.13775
BibTeX
@article{Aoyama2024,
author = {Aoyama, Toru and Maezawa, Yukio and Hashimoto, Itaru and Esashi, Ryuki and Yamamoto, Sosuke and Kazama, Keisuke and Numata, Koji and Uchiyama, Mamoru and Tamagawa, Ayako and Saito, Aya and Yukawa, Norio},
title = {Inflammatory Burden Index Is an Independent Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13775}
}
EUVIMED